Nordihydroguaiaretic acid: A review of its numerous and varied biological activities

Pharmaceutical Biology

Volumn 42, Issue 2, 2004, Pages 149-158

  Lambert, Joshua D ^a   Dorr, Robert T ^b   Timmermann, Barbara N ^c  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Ethnopharmacology; Larrea tridentata; Lignan; NDGA; Nordihydroguaiaretic acid

Indexed keywords

LIGNAN; NATURAL PRODUCT; NORDIHYDROGUAIARETIC ACID;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; CANCER THERAPY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; FERTILITY; HYPOGLYCEMIA; LARREA TRIDENTATA; LIVER TOXICITY; NEPHROTOXICITY; PLANT; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICOLOGY; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); LARREA TRIDENTATA; TRIDENTATA; ZYGOPHYLLACEAE;

EID: 9644274255     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1080/13880200490512016     Document Type: Review

References (81)

1. Adlercreutz H, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Arosemena P, Kellis Jr. J Vickery L (1993): Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44: 147-153.
2. Agarwal R, Wang Z, Bik D, Mukhtar H (1991): Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Met Disp 19: 620.
3. Anesini C, Genaro A, Cremaschi G, Boccio J, Zubillaga M, Borda LS, Borda E (1998): In vivo antitumor activity of Larrea divaricata C.: comparison of two routes of administration. Phytomedicine 5: 41-45.
4. Athar M, Raza H, Bickers DR, Mukhtar H (1990): Inhibition of benzoyl peroxide-mediated tumor promotion in 7,12-dimethylbenz(a)anthracene-initiated skin of Sencar mice by antioxidants nordihydroguaiaretic acid and diallyl sulfide. J Invest Dermatoll 94: 162-165.
5. Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, Martinez A, Mulshine JL (1996): Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97: 806-813.
6. Bernardi P (1999): Mitochondria in muscle cell death. Italian J Neurological Sci 20: 395-400.
7. Biswal SS, Datta K, Shaw SD, Feng X, Robertson JD Kehrer JP (2000): Glutathione oxidation and mitochondrial depolarization as mechanisms of nordihydroguaiaretic acid-induced apoptosis in lipoxygenase-deficient FL5.12 cells. Toxicol Sci 53: 77-83.
8. Bohnstedt C, Mabry T (1979): The volatile constituents of the genus Larrea (Zygophyllaceae). Rev Latinamericana Quim 10: 128-131.
9. Burk D, Woods M (1963): Hydrogen peroxide, catalase, quinones, nordihydroguaiaretic acid, and phosphopyridine nucleotides in relation to X-ray action on cancer cells. Radiation Res Suppl 3: 212-246.
10. Byczkowski JZ, Gessner T (1989): Effects of inhibition of NADPH: cytochrome P450 reductase on benzo(a)pyrene metabolism in mouse liver microsomes. Intl J Biochem 21: 525-529.
11. Caffrey P, Christen R, Sachdev O, Khandawala A, Howell S (1995): Modulation of vinblastine pharmacology in human tumor cells by meso-nordihydroguaiaretic acid. Cell Pharmacol 2: 75-80.
12. Calzado-Florez C, Segura-Luna J, Guajardo-Touche E (1995): Effects of chapparin, nordihydroguaiaretic acid and their structural analogues on Entamoeba histolytica cultures. Proc West Pharmacol Soc 38: 105-106.
13. Castetter E, Underbill R (1935): The ethnobiology of the Papago Indians. University of New Mexico Bulletin 4: 1-84.
14. Chen H, Teng L, Li JN, Park R, Mold DE, Gnabre J, Hwu JR, Tseng WN, Huang RC (1998): Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting Herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J Med Chem 41: 3001-3007.
15. Comber M, Sargent M (1991): Synthesis of larreantin, a novel cytotoxic napthoquinone from Larrea tridentata. J Chem Soc Chem Comm: 190-192.
16. Cook R, Ahmad N (1994): Potential role for lipoxygenase products of arachidonic acid in prostaglandin F2alpha-stimulated oxytocin release from the ovine corpus luteum. J Endocrinol 142: 47-52.
17. Cook R, Ahmad N (2000): Suppression of oxytocin-induced prostaglandin F2alpha release after intra-uterine nordihydroguaiaretic acid administration in ewes. Prostaglandins and Other Lipid Mediators 60: 27-33.
18. Craigo J, Callahan M, Huang RC, DeLucia AL (2000): Inhibition of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives. Antiviral Res 47: 19-28.
19. Diaz Barriga S, Madrigal-Bujaidar E, Marquez P (1999): Inhibitory effects of nordihydroguaiaretic acid on the frequency of micronuclei induced by methyl methanesulfonate in vivo. Mutation Res 44: 53-58.
20. Donnelly PJ, Stewart RK, Ali SL, Conlan AA, Reid KR, Petsikas D, Massey TE (1996): Biotransformation of aflatoxin B1 in human lung. Carcinogenesis 17: 2487-2494.
21. Encarnación RD, Garcia SK (1991): Antimicrobial screening of medicinal plants from Baja California Sur, Mexico. J Ethnopharmacol 31: 181-192.
22. Evan AP, Gardner KD (1979): Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 15: 7-19.
23. Gardner KD, Reed WP, Evan AP, Zedalis J, Hylarides MD, Leon AA (1987): Endotoxin provocation of experimental renal cystic disease. Kidney Int 32: 329-334.
24. Gezginci M, Timmermann B (2001): A short synthetic rout to nordihydroguaiaretic acid (NDGA) and its stereoisomer using Ti-induced carbonyl-coupling reaction. Tetrahedron Lett 42: 6083-6085.
25. Gisvold O, Thaker E (1974): Lignans from Larrea divaricata. J Pharm Sci 63: 1905-1907.
26. Gnabre J, Huang RCC, Bates RB, Burns JJ, Caldera S, Malcolmson ME, McClure KJ (1995a): Characterization of anti-HIV lignans from Larrea tridentata. Tetrahedron 51: 12203-12210.
27. Gnabre JN, Brady JN, Clanton DJ, Ito Y, Dittmer J, Bates RB, Huang RC (1995b): Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc Natl Acad Sci USA 92: 11239-11243.
28. Gonzalez-Coloma A, Wisdom C, Rundel P (1988): Ozone impact on the antioxidant nordihydroguaiaretic acid content in the external leaf resin of Larrea tridentata. Biochem Syst Ecol 16: 59-64.
29. Goodman T, Grice HC, Becking GC, Salem FA (1970): A cystic nephropathy induced by nordihydroguaiaretic acid in the rat. Light and electron microscopic investigations. Lab Invest 23: 93-107.
30. Gowri M, Reaven G, Azhar S (1999): Masoprocol lowers blood pressure in rats with fructose-induced hypertension. Am J Hypertension 12: 744-746.
31. Harper A, Kerr D, Gescher A, Chipman J (1999): Antioxidant effects of isoflavonoids and lignans, and protection against DNA oxidation. Free Rad Res 31: 149-161.
32. Heller JD, Kuo J, Wu TC, Kast WM, Huang RC (2001): Tetra-O-methyl nordihydroguaiaretic acid induces G2 arrest in mammalian cells and exhibits tumoricidal activity in vivo. Cancer Res 61: 5499-5504.
33. Heron S, Yarnell E (2001): The safety of low-dose Larrea tridentata (DC) Coville (creosote bush or chaparral): A retrospective clinical study. J Altern Complement Med 7: 175-185.
34. Hirose N, Doi F, Ueki T, Akazawa K, Chijiiwa K, Sugano M, Akimoto K, Shimizu S, Yamada H (1992): Suppressive effect of sesamin against 7,12-dimethylbenz[a]anthracene induced mammary carcinogenesis. Anticancer Res 12: 1259-1265.
35. Hoffmann J, Kingsolver B, McLaughlin S, Timmermann B (1984). Production of resins by arid-adapted Asteraceae. In Phytochemical Adaptations to Stress, ed. BN, Timmermann, Steelink C & Loewus F pp. 251-271. New York, NY: Plenum Press.
36. Hunter K, Betancourt J, Riddle B, Van Devender T, Cole K, Spaulding W (2001): Ploidy race distribution since the last glacial maximum in the North American desert shrub, Larrea tridentata. Global Ecol Biogeography 10: 521-533.
37. Kay M (1996): Healing with Plants in the American and Mexican West. Tucson, AZ, University of Arizona Press.
38. Kelly M, Xu J, Alexander K, Loo G (2001): Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutation Res 485: 309-318.
39. Konno C, Xue H-Z, Lu Z-Z, Ma B, Erdelmeier C, Che C-T, Cordell G, Soejarto D, Waller D, Fong H (1989): 1-Aryl tetralin lignans from Larrea tridentata. J Nat Prod 52: 1113-1117.
40. Konno C, Lu Z-Z, Xue H-Z, Erdelmeier C, Meksuriyen D, Che C-T, Cordell G, Soejarto D, Waller D, Fong H (1990): Furanoid lignans from Larrea tridentata. J Nat Prod 53: 396-406.
41. Kulp-Shorten CL, Konnikov N, Callen JP (1993): Comparative evaluation of the efficacy and safety of masoprocol and 5-fluorouracil cream for the treatment of multiple actinic keratoses of the head and neck. J Geriatr Dermatol 1: 161-168.
42. Kwon H, Park S, Lee S, Lee D, Yang C (2001): Determination of the binding constant of transcription factor AP-1 and DNA. Application of inhibitors. European J Biochem 268: 565-572.
43. Lambert JD, Meyers RO, Timmermann BN, Dorr RT (2001a): tetra-O-Methylnordihydroguaiaretic acid inhibits melanoma in vivo. Cancer Lett 171: 47-56.
44. Lambert JD, Meyers RO, Timmermann BN, Dorr RT (2001b): Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse. J Chromatog B 754: 85-90.
45. Levy S (1999): Creosote bush in Arizona sprouts new Herpes product. Drug Topics: 40.
46. Lia V, Confalonieri V, Comas C, Hunziker J (2001): Molecular phylogeny of Larrea and its allies (Zygophyllaceae): Reticulate evolution and the probable time of creosote bush arrival to North America. Mol Phylog Evol 21: 309-320.
47. Liu L, Massey TE (1992): Bioactivation of aflatoxin B1 by lipoxygenases, prostaglandin H synthase and cytochrome P450 monooxygenase in guinea-pig tissues. Carcinogenesis 13: 533-539.
48. Lundberg W, Halverson H, Burr G (1944): The antioxidant properties of nordihydroguaiaretic acid. Oil and Soap February: 33-35.
49. Luo J, Chuang T, Cheung J, Quan J, Tsai J, Sullivan C, Hector R, Reed M, Meszaros K, King S, Carlson T, Reaven G (1998): Masoprocol (nordihydroguaiaretic acid): A new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). European J Pharmacol 346: 77-79.
50. Luo Z, Meksuriyen D, Erdelmeier C, Fong H, Cordeil G (1988): Larreantin, a novel, cytotoxic napthoquinone from Larrea tridentata. J Org Chem 53: 2183-2185.
51. Mabry T, Difeo jr D, Sakakibara M, Bohnsted jr C, Seigler D (1977): The natural products chemistry of Larrea. In Creosote Bush, Biology and Chemistry of Larrea in New World Deserts, ed. Mabry T, Hunziker J, DiFeo jr, D pp. 115-134. Stroudsburg, PA: Dowden, Hutchinson, and Ross, Inc.
52. Madrigal-Bujaidar E, Diaz Barriga S, Cassani M, Marquez P, Revuelta P (1998): In vivo and in vitro antigenotoxic effect of nordihydroguaiaretic acid against SCE's induced by methyl methanesulfonate. Mutation Res 419: 163-168.
53. Martin M, Haourigui M, Pelissero C, Benassayag C, Nunez E (1996): Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 58: 429-436.
54. McCormick DL, Spicer AM (1987): Nordihydroguaiaretic acid suppression of rat mammary carcinogenesis induced by N-methyl-N-nitrosourea. Cancer Lett 37: 139-146.
55. Mikuni M, Yoshida M, Hellberg P, Peterson C, Edwin S, Brannstrom M, Peterson C (1998): The lipoxygenase inhibitor, nordihydroguaiaretic acid, inhibits ovulation and reduces leukotriene and prostaglandin levels in the rat ovary. Biolog Reprod 58: 1211-1216.
56. Moody TW, Leyton J, Martinez A, Hong S, Malkinson A, Mulshine JL (1998): Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth. Exp Lung Res 24: 617-628.
57. Moser M (1970): Seri: From conception through infancy. The Kiva 35: 201-210.
58. Nakadate T, Yamamoto S, Aizu E, Kato R (1989): Inhibition by lipoxygenase inhibitors of 7-bromomethylbenz[a]-anthracene-caused epidermal ornithine decarboxylase induction and skin tumor promotion in mice. Carcinogenesis 10: 2053-2057.
59. Olsen EA, Abernethy ML, Kulp-Shorten C, Callen JP, Glazer SD, Huntley A, McCray M, Monroe AB, Tschen E, Wolf JE, Jr. (1991): A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 24: 738-743.
60. Park S, Lee D, Yang C (1998): Inhibition of fos-jun-DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells. Cancer Lett 127: 23-28.
61. Parkinson A (1995): Biotransformation of xenobiotics. In Casarett and Doull's Toxicology, The Basic Science of Poisons, ed. Klaassen CD pp. 113-186. New York: McGraw-Hill Companies.
62. Reed M, Meszaros K, Entes L, Claypool M, Pinkett J, Brignetti D, Luo J, Khandwala A, Reaven G (1999): Effects of masoprocol on carbohydrate and lipid metabolism in a rat model of type II diabetes. Diabetologia 42: 102-106.
63. Rhoades D (1977): The antiherbivore chemistry of Larrea. In Creosote Bush, Biology and Chemistry of Larrea in New World Deserts, ed. Mabry T, Hunziker J, DiFeo jr, D pp. 135-175. Stroudsberg, PA: Dowden, Hutchinson, and Ross, Inc.
64. Sathyamoorthy N, Wang TT, Phang JM (1994): Stimulation of pS2 expression by diet-derived compounds. Cancer Res 54: 957-961.
65. Schultze-Mosgau MH, Dale IL, Gant TW, Chipman JK, Kerr DJ, Gescher A (1998): Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells. Eur J Cancer 34: 1425-1431.
66. Scribner K, Gadbois T, Gowri M, Azhar S, Reaven GM (2000): Masoprocol decreases serum triglyceride concentrations in rats with fructose-induced hypertriglyceridemia. Metabolism: Clinical and Experimental 49: 1106-1110.
67. Sheihk N, Philen R, Love L (1997): Chapparal-associated hepatotoxicity. Arch Int Med 157: 913-919.
68. Smart C, Hogle H, Robins R, Broom AD, Bartholomew D (1969): An interesting observation on nordihydroguaiaretic acid (NSC-4291; NDGA) and a patient with malignant melanoma - a preliminary report. Cancer Chemotherapy Reports Part 158: 147-151.
69. Smart C, Hogle H, Vogel H, Broom A, Batholomew D (1970): Clinical experience with nordihydroguaiaretic acid-chapparal tea in the treatment of cancer. Rocky Mountain Med J November: 39-43.
70. Smith AY, Feddersen RM, Gardner KD, Jr., Davis CJ, Jr. (1994): Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: A case report. J Urol 152: 2089-2091.
71. Snyder D, Castro R, Desforges J (1989): Antiproliferative effects of lipoxygenase inhibitors on malignant human hematopoietic cell lines. Exp Hematol 17: 6-9.
72. 2+ concentrations in C6 glioma cells. Neurochem Intl 40: 249-254.
73. Takasaki M, Konoshima T, Yasuda I, Hanamo T, Tokuda H (1997): Inhibitory effects of shouseiryu-to on two-stage carcinogenesis. II. Antitumor-promoting activities of two lignans from Asiasarum heterotropoides var. mandshuricum. Bio Pharm Bull 20: 776-780.
74. Tang D, Guan K-L, Li L, Honn K, Chen Y, Rice R, Taylor J, Porter A (1997): Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fats. Intl J Cancer 72: 1078-1087.
75. Tyler VE (1994): The Honest Herbal, a Sensible Guide to the Use of Herbs and Related Remedies. New York, Pharmaceutical Products Press.
76. Wagenknecht B, Gulbins E, Lang F, Dichgans J, Weller M (1997): Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells. FEBS Lett 409: 17-23.
77. Wagner P, Lewis R (1980): Interaction between activated nordihydroguaiaretic acid and deoxyribonucleic acid. Biochem Pharmacol 29: 3299-3306.
78. Waller C, Gisvold O (1945): A phytochemical investigation of Larrea divaricata Cav. J Am Pharm Assoc 34: 78-81.
79. Wilson DE, DiGianfilippo A, Ondrey FG, Anderson KM, Harris JE (1989): Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation. J Neurosurg 71: 551-557.
80. Xue H-Z, Lu Z-Z, Konno C, Soejarto D, Cordell G, Fong H, Hodgson W (1988): 3β-(3,4-Dihydroxycinnamoyl)-erythrodiol and 3β-(4- hydroxycinnamoyl)-erythrodiol from Larrea tridentata. Phytochemistry 27: 233-235.
81. Zamora J, Mora E, Parish E (1992): A comparison of the cytotoxicity of nordihydroguaiaretic acid and its derivatives. J Tennessee Acad Sci 67: 77-80.